This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Obesity » Weight Loss

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Metformin Therapy Is Effective in Nonobese Patients With Type 2 Diabetes

Posted: Thursday, November 09, 2006

There is now evidence-based data to support metformin use in nonobese individuals with type 2 diabetes."

Weight Loss Is The Key to Diabetes Prevention

Posted: Thursday, November 02, 2006

Every kilogram of weight loss resulted in 16% reduction of diabetes risk.

Diet Drug Acomplia Seen Needing More Testing as Diabetes Treatment

Posted: Thursday, November 02, 2006

Sanofi's highly anticipated diet drug Acomplia (rimonabant) may also be useful in helping obese diabetics control their blood sugar levels, but some respected researchers have expressed skepticism and called for additional testing in the prestigious British medical journal Lancet.

Pramlintide Continues Trials for Weight Loss

Posted: Thursday, November 02, 2006

Results of a Phase 2 study show a 8% reduction in weight. Pramlintide shows weight loss for those even without diabetes.

New Magic Weight-Loss Pill rimonabant (Acomplia) Offers Modest Results, Blocks 'Munchies'

Posted: Wednesday, October 25, 2006

A new drug billed as a magic bullet for obesity — rimonabant (Acomplia) — does help people lose weight, although not that much weight, and also helps lower cardiac risk factors, according to a review of studies.

Study: Leptin Has Powerful Effect on Reward Center in the Brain

Posted: Wednesday, October 25, 2006

Leptin, a hormone critical for normal food intake and metabolism, exerts a strong effect on appetite by acting in the mid-brain region as well as in the hypothalamus, according to a Yale School of Medicine study in Neuron.

FDA Approves Januvia for Diabetes

Posted: Thursday, October 19, 2006

The FDA announced the approval of Januvia (sitagliptin phosphate) Tablets, the first diabetes treatment approved in a new class of drugs known as DDP-4 inhibitors that enhances the body's own ability to lower elevated blood sugar.

Effect of Weight Loss on Arterial Stiffness in Type 2 Diabetes

Posted: Thursday, October 12, 2006

Moderate weight loss improves arterial stiffness in type 2 diabetes.

Exenatide As Effective As Insulin

Posted: Thursday, October 12, 2006

Patients on exenatide lost weight, while insulin patients gained weight.

EASD Recommends Earlier Insulin Therapy, Don’t Wait 4-6 years!

Posted: Thursday, September 28, 2006

A Consensus Report launched at the annual meeting of the European Association for the Study of Diabetes, in Copenhagen, Denmark, is calling for urgent action to drastically improve the management of diabetes, particularly urging the increased acceptance of insulin. All patients with Type 2 diabetes, if they live long enough will require insulin.